Medical Devices Series A Investors & VC Firms
1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.
Dow Venture Capital
MidlandSeed–Series A$250K – $5M
1 person
ARAX Capital Partners GmbH
ViennaSeed–Series A$2.2M
4 people
ePlanet Capital
San JoseSeed–Late Stage
3 people
Augere Venture
KrakówSeed–Late Stage
2 people
iD Ventures America, LLC
Santa ClaraSeed–Series A$500K – $3M
1 person
Shea Ventures, LLC
WalnutSeed–Series A
1 person
Pivotal bioVenture Partners China
ShanghaiSeed–Series A
4 people
Olympus Innovation Ventures
Seed–Growth
2 people
Omron Ventures
KyotoSeed–Growth
2 people
Alliance Jura-Hongrie Venture Capital Fund Management
BudapestSeries A–Series B$324K – $2.8M
1 person
Alpha Ventures
AthensSeries A–Series B$1.6M – $10.8M
1 person
Cutlass Capital, L.L.C.
BostonSeed–Late Stage$3M – $7M
1 person
Kenson Ventures, LLC
Menlo ParkSeed–Late Stage$500K – $3M
1 person
Company K Partners
SeoulSeries A–Series B
Vestel Ventures
IstanbulSeed–Series A
2 people
FFG Venture Business Partners
FukuokaPre-Seed–Growth
1 person
YouNick Mint
Suchy LasPre-Seed–Series A$2.7M
3 people
Wren Capital
LondonSeed–Series A
1 person
CRB Inverbío
MadridSeed–Series A
3 people
Wild Basin Investments
TexasSeed–Growth
2 people
Brandon Capital Partners
MelbourneSeed–Growth
1 person
Chang'an Capital
BeijingSeed–Series B
3 people
Novatio Ventures Inc.
TorontoSeed–Series A
3 people
Rhythm Venture Capital
New YorkSeed–Series A
3 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)Series A Investors & VC Firms in Global (2211)
Data sourced from public filings and firms' own websites — see our methodology.







